Development of Predictive Models to Inform a Novel Risk Categorization Framework for Antibiotic Resistance in E. coli- Causing Uncomplicated Urinary Tract Infection
Ryan K Shields,Wendy Y Cheng,Kalé Kponee-Shovein,Daniel Indacochea,Chi Gao,Fernando Kuwer,Ashish V Joshi,Fanny S Mitrani-Gold,Patrick Schwab,Diogo Ferrinho,Malena Mahendran,Lisa Pinheiro,Jimmy Royer,Madison T Preib,Jennifer Han,Richard Colgan
DOI: https://doi.org/10.1093/cid/ciae171
IF: 20.999
2024-04-05
Clinical Infectious Diseases
Abstract:In clinical practice, challenges in identifying patients with uncomplicated urinary tract infections (uUTIs) at risk of antibiotic non-susceptibility may lead to inappropriate prescribing and contribute to antibiotic resistance. We developed predictive models to quantify risk of non-susceptibility to four commonly prescribed antibiotic classes for uUTI, identify predictors of non-susceptibility to each class, and construct a corresponding risk categorization framework for non-susceptibility. Eligible females aged ≥12 years with E. coli- caused uUTI were identified from Optum's de-identified Electronic Health Record dataset (10/1/2015‒2/29/2020). Four predictive models were developed to predict non-susceptibility to each antibiotic class and a risk categorization framework was developed to classify patients' isolates as low, moderate, and high risk of non-susceptibility to each antibiotic class. Predictive models were developed among 87487 patients. Key predictors of having a non-susceptible isolate to ≥3 antibiotic classes included number of previous UTI episodes, prior β-lactam non-susceptibility, prior fluoroquinolone treatment, census bureau region, and race. The risk categorization framework classified 8.1%, 14.4%, 17.4%, and 6.3% of patients as having isolates at high risk of non-susceptibility to nitrofurantoin, trimethoprim-sulfamethoxazole, β-lactams, and fluoroquinolones, respectively. Across classes, the proportion of patients categorized as having high-risk isolates was 3–12 folds higher among patients with non-susceptible isolates versus susceptible isolates. Our predictive models highlight factors that increase risk of non-susceptibility to antibiotics for uUTIs, while the risk categorization framework contextualizes risk of non-susceptibility to these treatments. Our findings provide valuable insight to clinicians treating uUTIs and may help inform empiric prescribing in this population.
immunology,infectious diseases,microbiology